Announcements Trials
Browse Landscape

Phase

Phase NA 1

Status

Completed 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Endocrine 1

Conditions

Breast Neoplasms 3Gastroesophageal Reflux 2Zollinger-Ellison Syndrome 1Xerostomia 1Uterine Neoplasms 1Uterine Cervical Neoplasms 1Stomach Neoplasms 1Pseudomyxoma Peritonei 1Oropharyngeal Neoplasms 1Multiple Endocrine Neoplasia 1Mucositis 1Lymphoma, B-Cell, Marginal Zone 1Leukemia, B-Cell 1Helicobacter Infections 1Heartburn 1Head and Neck Neoplasms 1Gastritis, Atrophic 1Endometrial Neoplasms 1Carcinoma, Neuroendocrine 1Carcinoid Tumor 1Barrett Esophagus 1Appendiceal Neoplasms 1

Interventions

Everolimus 7Nivolumab 6Cisplatin 6Temozolomide 5Bevacizumab 5lutetium Lu 177 dotatate 4Fluorouracil 4Carboplatin 4pembrolizumab 3avelumab 3atezolizumab 3Irinotecan 3Ipilimumab 3Etoposide 3Capecitabine 3surufatinib 2sintilimab 2gallium Ga 68 dotatate 2dostarlimab 2Radiosurgery 2Positron Emission Tomography Computed Tomography 2Paclitaxel 2PE regimen 2N-(2-amino-5-fluorobenzyl)-4-(N-(pyridine-3-acrylyl)aminomethyl)benzamide 2Magnetic Resonance Imaging 2Immunoglobulin G 2IFL protocol 2Fluorodeoxyglucose F18 2Drug Therapy 2Disulfides 2

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
OTHER × Carcinoma, Neuroendocrine × Lansoprazole × Clear all
NCT01216267 2013-01-16

Evaluation of Methods for the Determination of Chromogranin A in Routine Blood Samples

University of Western Ontario, Canada

Phase NA Completed
200 enrolled
Endocrine

Carcinoid Tumor, Carcinoma, Neuroendocrine

Data powered by HemOnc (CC BY 4.0) Colophon âš¡